Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eyelid Neoplasms | 10 | 2017 | 89 | 2.640 |
Why?
|
Eyelid Diseases | 9 | 2024 | 157 | 2.240 |
Why?
|
Eye Neoplasms | 7 | 2022 | 307 | 2.220 |
Why?
|
Adenocarcinoma, Sebaceous | 5 | 2022 | 21 | 1.940 |
Why?
|
Orbital Neoplasms | 8 | 2024 | 222 | 1.840 |
Why?
|
Granuloma, Foreign-Body | 3 | 2022 | 42 | 1.720 |
Why?
|
Conjunctival Neoplasms | 9 | 2024 | 77 | 1.590 |
Why?
|
Sebaceous Gland Neoplasms | 5 | 2022 | 40 | 1.530 |
Why?
|
Mucopolysaccharidosis I | 2 | 2021 | 52 | 1.490 |
Why?
|
Exophthalmos | 2 | 2023 | 97 | 1.410 |
Why?
|
Eyelids | 10 | 2024 | 278 | 1.410 |
Why?
|
Stevens-Johnson Syndrome | 2 | 2024 | 246 | 1.360 |
Why?
|
Eye | 3 | 2022 | 712 | 1.330 |
Why?
|
Eye Diseases | 3 | 2023 | 653 | 1.220 |
Why?
|
Corneal Diseases | 4 | 2021 | 542 | 1.180 |
Why?
|
Conjunctival Diseases | 4 | 2021 | 110 | 1.100 |
Why?
|
Orbit | 6 | 2023 | 457 | 1.090 |
Why?
|
Neuroectodermal Tumors, Primitive | 6 | 2016 | 136 | 1.070 |
Why?
|
Lacrimal Apparatus Diseases | 5 | 2022 | 72 | 1.010 |
Why?
|
Sweat Gland Neoplasms | 3 | 2022 | 116 | 0.980 |
Why?
|
Conjunctiva | 9 | 2022 | 479 | 0.970 |
Why?
|
Skin Neoplasms | 11 | 2023 | 5821 | 0.910 |
Why?
|
Conjunctivitis | 1 | 2024 | 155 | 0.870 |
Why?
|
Glomus Tumor | 1 | 2023 | 62 | 0.850 |
Why?
|
Shaken Baby Syndrome | 1 | 2022 | 24 | 0.850 |
Why?
|
Syringoma | 1 | 2022 | 8 | 0.840 |
Why?
|
Pseudomonas | 1 | 2022 | 124 | 0.810 |
Why?
|
Silver | 1 | 2022 | 117 | 0.790 |
Why?
|
Angioedema | 1 | 2023 | 184 | 0.770 |
Why?
|
Silicones | 1 | 2022 | 228 | 0.770 |
Why?
|
Cysts | 6 | 2017 | 681 | 0.720 |
Why?
|
Melanoma | 7 | 2024 | 5709 | 0.710 |
Why?
|
Lymphoma, Follicular | 1 | 2024 | 457 | 0.680 |
Why?
|
Exanthema | 1 | 2024 | 503 | 0.660 |
Why?
|
Edema | 1 | 2023 | 766 | 0.650 |
Why?
|
Uveal Neoplasms | 5 | 2024 | 341 | 0.650 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2022 | 178 | 0.640 |
Why?
|
Lacrimal Apparatus | 5 | 2021 | 223 | 0.630 |
Why?
|
Diplopia | 2 | 2024 | 214 | 0.620 |
Why?
|
Pathology | 1 | 2021 | 270 | 0.610 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.610 |
Why?
|
Craniocerebral Trauma | 1 | 2022 | 490 | 0.610 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 118 | 0.600 |
Why?
|
Facial Bones | 1 | 2019 | 208 | 0.600 |
Why?
|
Lymphoma | 2 | 2024 | 1901 | 0.600 |
Why?
|
Cytomegalovirus Infections | 1 | 2024 | 831 | 0.580 |
Why?
|
RANK Ligand | 1 | 2019 | 318 | 0.580 |
Why?
|
Corneal Transplantation | 1 | 2021 | 321 | 0.570 |
Why?
|
Granuloma, Pyogenic | 1 | 2016 | 47 | 0.520 |
Why?
|
Diagnosis, Differential | 16 | 2024 | 12974 | 0.510 |
Why?
|
Child Abuse | 2 | 2022 | 1077 | 0.510 |
Why?
|
Keratosis, Seborrheic | 1 | 2015 | 27 | 0.510 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2057 | 0.510 |
Why?
|
Neurofibroma | 1 | 2016 | 95 | 0.500 |
Why?
|
Vision Disorders | 1 | 2022 | 1088 | 0.500 |
Why?
|
In Situ Hybridization | 1 | 2019 | 1900 | 0.490 |
Why?
|
Sarcoma, Synovial | 1 | 2016 | 153 | 0.490 |
Why?
|
Papilloma, Inverted | 1 | 2014 | 19 | 0.490 |
Why?
|
Headache | 1 | 2022 | 1256 | 0.470 |
Why?
|
Biopsy | 15 | 2024 | 6766 | 0.460 |
Why?
|
Orbital Diseases | 4 | 2017 | 178 | 0.450 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 698 | 0.450 |
Why?
|
Nasolacrimal Duct | 3 | 2022 | 79 | 0.450 |
Why?
|
Neuroma | 1 | 2016 | 133 | 0.440 |
Why?
|
Retinoblastoma | 1 | 2016 | 317 | 0.430 |
Why?
|
Molecular Biology | 1 | 2016 | 576 | 0.420 |
Why?
|
Oculomotor Muscles | 4 | 2024 | 406 | 0.410 |
Why?
|
Skin Diseases | 2 | 2021 | 1094 | 0.390 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2244 | 0.380 |
Why?
|
Papillomavirus Infections | 3 | 2021 | 1613 | 0.380 |
Why?
|
Dermatology | 1 | 2021 | 918 | 0.370 |
Why?
|
Skin | 2 | 2024 | 4484 | 0.370 |
Why?
|
Humans | 94 | 2024 | 761504 | 0.370 |
Why?
|
Hyperpigmentation | 2 | 2022 | 117 | 0.360 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1666 | 0.360 |
Why?
|
Immunohistochemistry | 12 | 2021 | 11076 | 0.360 |
Why?
|
Melanosis | 3 | 2024 | 93 | 0.360 |
Why?
|
Neurilemmoma | 1 | 2016 | 526 | 0.350 |
Why?
|
Ciliary Body | 3 | 2016 | 167 | 0.350 |
Why?
|
Skin Ulcer | 2 | 2024 | 130 | 0.330 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2021 | 4026 | 0.330 |
Why?
|
Strabismus | 2 | 2024 | 317 | 0.320 |
Why?
|
Retinal Hemorrhage | 2 | 2022 | 95 | 0.320 |
Why?
|
Ophthalmologic Surgical Procedures | 5 | 2024 | 354 | 0.320 |
Why?
|
Dacryocystitis | 2 | 2022 | 68 | 0.310 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1606 | 0.300 |
Why?
|
Cornea | 3 | 2021 | 1333 | 0.300 |
Why?
|
Retrospective Studies | 25 | 2024 | 80636 | 0.300 |
Why?
|
Eosinophilia | 2 | 2023 | 560 | 0.300 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7407 | 0.280 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.280 |
Why?
|
Eye Burns | 2 | 2017 | 65 | 0.270 |
Why?
|
Immunoenzyme Techniques | 5 | 2015 | 1705 | 0.270 |
Why?
|
Burns, Chemical | 2 | 2017 | 123 | 0.260 |
Why?
|
Hair Diseases | 2 | 2016 | 72 | 0.260 |
Why?
|
Glucose Transporter Type 1 | 2 | 2016 | 186 | 0.250 |
Why?
|
Epidermal Cyst | 2 | 2016 | 64 | 0.250 |
Why?
|
Immunocompromised Host | 2 | 2024 | 856 | 0.250 |
Why?
|
Cellulitis | 2 | 2024 | 209 | 0.250 |
Why?
|
Keratin-14 | 2 | 2014 | 56 | 0.240 |
Why?
|
Human papillomavirus 16 | 2 | 2017 | 267 | 0.240 |
Why?
|
Female | 47 | 2024 | 392644 | 0.240 |
Why?
|
Middle Aged | 36 | 2024 | 220895 | 0.240 |
Why?
|
Radiodermatitis | 1 | 2024 | 60 | 0.240 |
Why?
|
Mite Infestations | 1 | 2024 | 10 | 0.230 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2024 | 40 | 0.230 |
Why?
|
Skin Diseases, Viral | 1 | 2024 | 26 | 0.230 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2024 | 33 | 0.230 |
Why?
|
Eye Infections, Parasitic | 1 | 2024 | 26 | 0.230 |
Why?
|
Retinal Neoplasms | 2 | 2016 | 146 | 0.230 |
Why?
|
Melanocytes | 3 | 2024 | 509 | 0.230 |
Why?
|
Male | 45 | 2024 | 360804 | 0.230 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5840 | 0.230 |
Why?
|
Choristoma | 2 | 2016 | 206 | 0.230 |
Why?
|
Exudates and Transudates | 1 | 2024 | 174 | 0.220 |
Why?
|
Antigens, CD34 | 2 | 2016 | 658 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2021 | 2825 | 0.220 |
Why?
|
Prostheses and Implants | 2 | 2022 | 1271 | 0.210 |
Why?
|
Perineum | 1 | 2024 | 208 | 0.210 |
Why?
|
Sclera | 1 | 2024 | 190 | 0.210 |
Why?
|
Keratin-17 | 3 | 2022 | 26 | 0.210 |
Why?
|
Hemochromatosis | 1 | 2024 | 174 | 0.200 |
Why?
|
Optic Atrophy | 1 | 2023 | 79 | 0.200 |
Why?
|
Cartilage | 2 | 2016 | 806 | 0.200 |
Why?
|
Doxycycline | 1 | 2024 | 344 | 0.200 |
Why?
|
Ophthalmia, Sympathetic | 1 | 2021 | 18 | 0.190 |
Why?
|
Lacrimal Duct Obstruction | 1 | 2022 | 53 | 0.190 |
Why?
|
Minocycline | 1 | 2022 | 169 | 0.190 |
Why?
|
Color | 1 | 2022 | 299 | 0.190 |
Why?
|
Anal Canal | 1 | 2024 | 373 | 0.190 |
Why?
|
Erythema | 1 | 2022 | 262 | 0.190 |
Why?
|
Wet Macular Degeneration | 1 | 2023 | 162 | 0.190 |
Why?
|
Glucocorticoids | 6 | 2024 | 2161 | 0.190 |
Why?
|
Dacryocystorhinostomy | 1 | 2022 | 78 | 0.180 |
Why?
|
Papilloma | 1 | 2021 | 140 | 0.180 |
Why?
|
Aged | 18 | 2024 | 169289 | 0.180 |
Why?
|
Nevus | 1 | 2022 | 205 | 0.170 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8547 | 0.170 |
Why?
|
Keratins | 3 | 2016 | 498 | 0.170 |
Why?
|
Retinal Diseases | 2 | 2017 | 705 | 0.170 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2015 | 491 | 0.170 |
Why?
|
Choroidal Neovascularization | 1 | 2023 | 363 | 0.170 |
Why?
|
Hydroxychloroquine | 1 | 2024 | 426 | 0.170 |
Why?
|
Cytomegalovirus | 1 | 2024 | 756 | 0.170 |
Why?
|
Nose Neoplasms | 1 | 2021 | 249 | 0.160 |
Why?
|
Adult | 24 | 2024 | 221177 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 218 | 0.160 |
Why?
|
Craniosynostoses | 1 | 2023 | 412 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 9 | 2024 | 20570 | 0.160 |
Why?
|
Keratin-7 | 2 | 2016 | 55 | 0.150 |
Why?
|
Abdomen | 1 | 2024 | 1128 | 0.150 |
Why?
|
Hidrocystoma | 1 | 2017 | 11 | 0.150 |
Why?
|
Anophthalmos | 1 | 2017 | 23 | 0.140 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 283 | 0.140 |
Why?
|
Apocrine Glands | 1 | 2017 | 32 | 0.140 |
Why?
|
Ectropion | 1 | 2017 | 27 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2024 | 1189 | 0.140 |
Why?
|
Carcinoma, Basal Cell | 1 | 2022 | 560 | 0.140 |
Why?
|
Eccrine Glands | 1 | 2017 | 52 | 0.140 |
Why?
|
Pilomatrixoma | 1 | 2016 | 24 | 0.140 |
Why?
|
Silicone Oils | 1 | 2016 | 22 | 0.140 |
Why?
|
Endotamponade | 1 | 2016 | 37 | 0.140 |
Why?
|
Eyebrows | 1 | 2016 | 37 | 0.130 |
Why?
|
Blepharitis | 1 | 2016 | 35 | 0.130 |
Why?
|
Retinal Vasculitis | 1 | 2016 | 46 | 0.130 |
Why?
|
Anterior Capsule of the Lens | 1 | 2015 | 3 | 0.130 |
Why?
|
Mucorales | 1 | 2016 | 35 | 0.130 |
Why?
|
Epiretinal Membrane | 1 | 2016 | 73 | 0.130 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2016 | 37 | 0.130 |
Why?
|
Pigmentation | 1 | 2016 | 144 | 0.130 |
Why?
|
Orbital Myositis | 1 | 2016 | 25 | 0.130 |
Why?
|
HMGA2 Protein | 1 | 2016 | 102 | 0.130 |
Why?
|
Myofibromatosis | 1 | 2016 | 27 | 0.130 |
Why?
|
Blepharoplasty | 1 | 2016 | 61 | 0.130 |
Why?
|
Orbital Pseudotumor | 1 | 2016 | 42 | 0.130 |
Why?
|
Adenoma, Pleomorphic | 1 | 2016 | 75 | 0.130 |
Why?
|
Goldenhar Syndrome | 1 | 2016 | 39 | 0.130 |
Why?
|
Myofibroma | 1 | 2016 | 45 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1007 | 0.130 |
Why?
|
Ki-67 Antigen | 2 | 2015 | 629 | 0.130 |
Why?
|
Iris Diseases | 1 | 2015 | 37 | 0.130 |
Why?
|
Eye Infections, Viral | 1 | 2016 | 60 | 0.130 |
Why?
|
Human papillomavirus 18 | 1 | 2016 | 125 | 0.130 |
Why?
|
Histiocytes | 1 | 2015 | 98 | 0.120 |
Why?
|
Scotoma | 1 | 2016 | 130 | 0.120 |
Why?
|
Retinoscopy | 1 | 2015 | 26 | 0.120 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2016 | 767 | 0.120 |
Why?
|
S100 Proteins | 1 | 2016 | 218 | 0.120 |
Why?
|
Eye Infections, Fungal | 1 | 2016 | 100 | 0.120 |
Why?
|
Mucormycosis | 1 | 2016 | 103 | 0.120 |
Why?
|
Corneal Neovascularization | 1 | 2017 | 185 | 0.120 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2015 | 39 | 0.120 |
Why?
|
Gliosis | 1 | 2015 | 245 | 0.120 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2016 | 114 | 0.120 |
Why?
|
Granuloma | 1 | 2017 | 328 | 0.120 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2015 | 70 | 0.120 |
Why?
|
Papillomaviridae | 2 | 2021 | 1119 | 0.120 |
Why?
|
Brain | 1 | 2021 | 27112 | 0.120 |
Why?
|
Dermis | 1 | 2016 | 202 | 0.120 |
Why?
|
Mouth Mucosa | 1 | 2017 | 432 | 0.120 |
Why?
|
Myxoma | 1 | 2014 | 114 | 0.110 |
Why?
|
Fibroblasts | 1 | 2024 | 4141 | 0.110 |
Why?
|
Retina | 2 | 2022 | 2659 | 0.110 |
Why?
|
Infant | 7 | 2022 | 36192 | 0.110 |
Why?
|
Hair Follicle | 1 | 2016 | 211 | 0.110 |
Why?
|
Rupture, Spontaneous | 1 | 2014 | 362 | 0.110 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 350 | 0.110 |
Why?
|
Pituitary Gland | 1 | 2016 | 635 | 0.110 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2015 | 169 | 0.110 |
Why?
|
Retinal Pigment Epithelium | 1 | 2016 | 303 | 0.110 |
Why?
|
Choroid Neoplasms | 1 | 2014 | 177 | 0.110 |
Why?
|
Myotonic Dystrophy | 1 | 2014 | 78 | 0.110 |
Why?
|
Rhabdomyosarcoma | 1 | 2016 | 358 | 0.110 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2016 | 237 | 0.110 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 694 | 0.100 |
Why?
|
Pathology, Molecular | 1 | 2016 | 328 | 0.100 |
Why?
|
Carcinoma, Lobular | 1 | 2017 | 481 | 0.100 |
Why?
|
Rhabdoid Tumor | 1 | 2014 | 210 | 0.100 |
Why?
|
Adolescent | 11 | 2024 | 88319 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2024 | 58976 | 0.100 |
Why?
|
Prosthesis Implantation | 1 | 2017 | 592 | 0.100 |
Why?
|
Respiratory Mucosa | 1 | 2016 | 439 | 0.100 |
Why?
|
Giant Cell Arteritis | 1 | 2016 | 306 | 0.100 |
Why?
|
Pregnancy Complications | 2 | 2016 | 2947 | 0.100 |
Why?
|
Retinal Detachment | 1 | 2016 | 428 | 0.100 |
Why?
|
Child | 7 | 2022 | 80153 | 0.100 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4544 | 0.100 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2014 | 103 | 0.100 |
Why?
|
Inflammation | 2 | 2024 | 10773 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8465 | 0.100 |
Why?
|
Actins | 2 | 2016 | 2050 | 0.100 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1560 | 0.090 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2015 | 339 | 0.090 |
Why?
|
Mucin-1 | 1 | 2016 | 540 | 0.090 |
Why?
|
Young Adult | 8 | 2019 | 59243 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 11 | 2024 | 36426 | 0.090 |
Why?
|
Vascular Malformations | 1 | 2015 | 468 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2017 | 1085 | 0.090 |
Why?
|
Retinal Vessels | 1 | 2015 | 852 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9318 | 0.080 |
Why?
|
Visual Fields | 1 | 2016 | 1062 | 0.080 |
Why?
|
DNA, Viral | 1 | 2016 | 2202 | 0.080 |
Why?
|
Pain | 1 | 2024 | 5073 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17904 | 0.080 |
Why?
|
Antigens, CD | 1 | 2018 | 4003 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3595 | 0.070 |
Why?
|
Child, Preschool | 7 | 2019 | 42230 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1405 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6075 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.070 |
Why?
|
Neoplasm Proteins | 5 | 2016 | 3617 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1897 | 0.060 |
Why?
|
B-Lymphocytes | 2 | 2017 | 4758 | 0.060 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3156 | 0.060 |
Why?
|
Eye Enucleation | 2 | 2016 | 128 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2508 | 0.060 |
Why?
|
Mites | 1 | 2024 | 46 | 0.060 |
Why?
|
Limbus Corneae | 2 | 2016 | 144 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2917 | 0.060 |
Why?
|
Orbital Cellulitis | 1 | 2024 | 33 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14666 | 0.060 |
Why?
|
Lichen Planus | 1 | 2024 | 70 | 0.050 |
Why?
|
Pigmentation Disorders | 1 | 2024 | 105 | 0.050 |
Why?
|
Ileum | 1 | 2005 | 557 | 0.050 |
Why?
|
Brain Injuries | 1 | 2015 | 2053 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11121 | 0.050 |
Why?
|
Visual Acuity | 3 | 2016 | 2672 | 0.050 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2005 | 326 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12690 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2017 | 10194 | 0.050 |
Why?
|
Intravitreal Injections | 1 | 2023 | 385 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8654 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2016 | 12795 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16591 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2017 | 39106 | 0.050 |
Why?
|
Antirheumatic Agents | 2 | 2024 | 1372 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2023 | 673 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 4352 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2017 | 21012 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9606 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1152 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3816 | 0.040 |
Why?
|
Siblings | 1 | 2023 | 825 | 0.040 |
Why?
|
Alopecia | 1 | 2023 | 412 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9280 | 0.040 |
Why?
|
Growth Disorders | 1 | 2023 | 655 | 0.040 |
Why?
|
HIV Infections | 1 | 2024 | 17351 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2017 | 15631 | 0.040 |
Why?
|
Emulsions | 1 | 2016 | 152 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 2017 | 200 | 0.030 |
Why?
|
Drug Implants | 1 | 2017 | 230 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13639 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2049 | 0.030 |
Why?
|
Keratin-18 | 1 | 2016 | 38 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4915 | 0.030 |
Why?
|
Microscopy, Acoustic | 1 | 2015 | 47 | 0.030 |
Why?
|
Curettage | 1 | 2015 | 74 | 0.030 |
Why?
|
Acyclovir | 1 | 2016 | 268 | 0.030 |
Why?
|
Triamcinolone | 1 | 2015 | 68 | 0.030 |
Why?
|
Herpesvirus 3, Human | 1 | 2016 | 159 | 0.030 |
Why?
|
Valine | 1 | 2016 | 408 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2015 | 280 | 0.030 |
Why?
|
Vitreous Body | 1 | 2016 | 399 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2016 | 411 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2022 | 1993 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2015 | 553 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2016 | 583 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 74206 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 64680 | 0.030 |
Why?
|
Debridement | 1 | 2016 | 494 | 0.030 |
Why?
|
Vitrectomy | 1 | 2016 | 392 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2023 | 2047 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2017 | 962 | 0.030 |
Why?
|
Tomography, Optical Coherence | 2 | 2016 | 2917 | 0.030 |
Why?
|
Ultrasonography | 2 | 2015 | 5972 | 0.020 |
Why?
|
Incidental Findings | 1 | 2017 | 697 | 0.020 |
Why?
|
Goblet Cells | 1 | 2015 | 298 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1626 | 0.020 |
Why?
|
Antifungal Agents | 1 | 2016 | 752 | 0.020 |
Why?
|
Gene Dosage | 1 | 2015 | 1217 | 0.020 |
Why?
|
Epigenomics | 1 | 2016 | 943 | 0.020 |
Why?
|
Morbidity | 1 | 2016 | 1750 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2015 | 1085 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4772 | 0.020 |
Why?
|
Gene Amplification | 1 | 2015 | 1089 | 0.020 |
Why?
|
Neuroglia | 1 | 2015 | 956 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7529 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2510 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2015 | 1079 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2606 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9177 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2707 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4021 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3778 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5869 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 26198 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8529 | 0.020 |
Why?
|
Pregnancy | 2 | 2016 | 29874 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 3060 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18252 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2005 | 2678 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11528 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2015 | 7856 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20098 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 8181 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 7396 | 0.010 |
Why?
|
Animals | 2 | 2017 | 168459 | 0.010 |
Why?
|
Rats | 1 | 2005 | 23742 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2005 | 15842 | 0.000 |
Why?
|